These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4956328)

  • 21. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo].
    Belogurova VP; Gorislavets II; Ivanitskaia NN
    Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of hypothyroidism on the course of experimental tuberculosis. I. Infection with tubercle bacilli resistant to INH].
    Pawczyński C
    Gruzlica; 1968 Apr; 36(4):293-303. PubMed ID: 4175705
    [No Abstract]   [Full Text] [Related]  

  • 23. Symposium on drug resistant tuberculosis. Reserve drug combinations.
    Mitchison DA
    J Ir Med Assoc; 1970 Mar; 63(393):86-91. PubMed ID: 4984341
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 25. [Epidemiological importance of resistant strains of Mycobacterium tuberculosis (experimental study)].
    Chertkova EI; Udilova NN; Chernigovskaia NN
    Probl Tuberk; 1966; 44(7):67-71. PubMed ID: 4969292
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
    Uvarova OA; Zemskova ZS; Stukalova BIa; Afanas'eva IuP
    Farmakol Toksikol; 1967; 30(4):474-7. PubMed ID: 4877410
    [No Abstract]   [Full Text] [Related]  

  • 28. [The biological properties and virulence of a lysogenic strain from an SM-resistant strain of Mycobacterium tuberculosis].
    Nakano H; Sushida K
    Kekkaku; 1985 Nov; 60(11):577-84. PubMed ID: 3937930
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in the biological properties of Mycobacterium tuberculosis as affected by x-ray radiation].
    Golyshevskaia VI; Bibergal' EA
    Probl Tuberk; 1986; (9):47-50. PubMed ID: 3097634
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 31. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The virulence of Mycobacterium tuberculosis strains resistant to rifampicin. (Preliminary note)].
    Daddi G; Lucchesi M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(1):29-33. PubMed ID: 4996681
    [No Abstract]   [Full Text] [Related]  

  • 33. Tuberculosis: the return of an old enemy.
    Collins FM
    Crit Rev Microbiol; 1993; 19(1):1-16. PubMed ID: 8481210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An experimental study on the antituberculous activity of tuberactiomycin-N].
    Toyoara M
    Kekkaku; 1972 Jun; 47(6):181-7. PubMed ID: 4628191
    [No Abstract]   [Full Text] [Related]  

  • 35. Results of the study of the W 115 M. tuberculosis vaccine strain and the lyophilized experimental vaccine W 115.
    Weiszfeiler JG
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):492-7. PubMed ID: 812909
    [No Abstract]   [Full Text] [Related]  

  • 36. [Resistance and virulence of mycobacteria. Clinical and experimental studies].
    Lucchesi M
    Ftiziologia; 1971; 20(4):401-4. PubMed ID: 5005707
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in tuberculosis].
    Freerksen E
    Internist (Berl); 1978 Mar; 19(3):156-60. PubMed ID: 417040
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the infection of drug-resistant tubercle bacilli. 3. Experimental studies on the infection of INH highly-resistant tubercle bacilli].
    Osato T; Toyohara M; Aoki M; Hatori H
    Kekkaku; 1968 Nov; 43(11):473-9. PubMed ID: 4975533
    [No Abstract]   [Full Text] [Related]  

  • 40. [Virulence of rifampicin-resistant tubercle bacilli for experimental animals (preliminary report)].
    Osato T; Shimizu H
    Kekkaku; 1972 May; 47(5):129-34. PubMed ID: 4625370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.